IceCure Medical (ICCM) Debt to Equity (2020 - 2025)

IceCure Medical (ICCM) reported Debt to Equity of $0.0 for Q4 2025, down 93.84% year-over-year from $0.02 in Q4 2024, and down 93.84% on a QoQ basis from $0.02 in Q4 2024.

IceCure Medical (ICCM) has 4 years of Debt to Equity data on file, last reported at $0.0 in Q4 2025.

  • Quarterly Debt to Equity fell 93.84% year-over-year to $0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.0 (down 93.84% YoY) and the FY2025 annual result came in at $0.0, down 93.84% from the prior year.
  • Debt to Equity slipped to $0.0 in Q4 2025 per ICCM's latest filing, from $0.02 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.02 in Q4 2024 and bottomed at $0.0 in Q4 2025.
  • The 3-year median for Debt to Equity is $0.02 (2021), against an average of $0.02.
  • The widest annual swing landed in 2021, when Debt to Equity tumbled 82.94%; it then plunged 93.84% in 2025.
  • Tracing ICCM's Debt to Equity over 3 years: stood at $0.02 in 2021, then gained by 1.77% to $0.02 in 2024, then sank by 93.84% to $0.0 in 2025.
  • Per Business Quant, the three latest ICCM Debt to Equity figures stand at $0.0 (Q4 2025), $0.02 (Q4 2024), and $0.02 (Q4 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00
Dec 31, 2024 0.02
Dec 31, 2021 0.02
Dec 31, 2020 0.13